Continuous glucose monitoring cut mean A1C from 8.8% to 7.2% over 26 weeks in adults with type 2 diabetes not on insulin, 0.9 points more than routine care in the CONNECT trial.
News|Articles|February 23, 2024
Results: MHE Question of the Week #4
Author(s)MHE Staff
The results of this week’s poll about Medicaid work requirements.
Advertisement
This week, we asked our readers if they were for or against Medicaid work requirements. The results are in, and no one was in favor of the requirements.
Under the Trump Administration, 13 states were granted federally approved work requirements, but starting in Feb. 2021, the Biden Administration withdrew these approvals, according to
We want to know what you’re thinking! Every Monday morning at 8:30 a.m. E.T. the editors of Managed Healthcare Executive are posing a question to our readers about a timely issue in U.S. healthcare. We collect your answers until 11 a.m. E.T. on Friday.
Advertisement
Related to this article
American Oncology Network’s Melody Chang, R.Ph., says 18% of its first 70 outpatient bispecific patients had CRS, all low grade with no hospitalizations.
A screening program in eight countries found early-stage type 1 diabetes in about 1 in 350 children with no family history of the disease.
UC Davis Health’s Tiffany Phung, Pharm.D., and Tim Cutler, Pharm.D., say staff-driven ideas protect research independence in industry partnerships.
UC Davis Health’s Tiffany Phung, Pharm.D., and Tim Cutler, Pharm.D., say research justifies services and opens doors to limited distribution drugs.
Garza, an expert on hidradenitis suppurativa at Johns Hopkins, says increasing incidence of the disease on the Japanese island of Okinawa offer some "tantalizing clues" about reasons for the rising incidence.
Apothecary Pharma is recalling 22 vials of compounded tirzepatide and one NAD+ vial nationwide, citing a lack of assurance of sterility.
Pooja Roy, M.D., of Houston Methodist Hospital, discusses how Precedex (dexmedetomidine), an ICU sedative, sometimes triggers noninfectious fever, sparking costly sepsis workups, and the need for a test could help clinicians identify the drug as a cause of fever in ICUs.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Rex Hoffman, M.D., on physician burnout and collaborative leadership | HSES 2026
2
Rex Hoffman, M.D., on how a CMO balances competing priorities | HSES 2026
3
Apothecary Pharma recalls compounded tirzepatide and NAD+ vials over sterility concerns
4
GLP-1 therapy tied to lower mortality and liver decompensation in older adults with MASLD
5